AMINO ACIDS FOR CELL HEALTH - Trademark Details
Status: 700 - Registered
Serial Number
87062066
Registration Number
5347989
Word Mark
AMINO ACIDS FOR CELL HEALTH
Status
700 - Registered
Status Date
2017-11-28
Filing Date
2016-06-06
Registration Number
5347989
Registration Date
2017-11-28
Mark Drawing
4000 - Standard character mark
Typeset
Attorney Name
Law Office Assigned Location Code
L10
Employee Name
MAKHDOOM, SAIMA
Statements
Disclaimer with Predetermined Text
"AMINO ACIDS"
Goods and Services
proteins, biochemicals in the nature of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in scientific and medical research; nutrients and nutritive products, namely, proteins in the nature of polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of beverages, food products and food supplements for human and non-human use; proteins for the food industry in the nature of proteins, polypeptides, peptides, amino acids, and small molecules in the nature of organic compounds and metabolites for use in the manufacture of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; biochemicals for in vitro and in vivo scientific research
Goods and Services
pharmaceutical preparations and agents for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; proteins, polypeptides, peptides, amino acids, and small molecules being a featured component of pharmaceutical preparations pharmaceutical for the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement; medicines, namely proteins, biomolecules in the nature of of polypeptides and peptides, amino acids, and small molecules in the nature of organic compounds and amino acid metabolites; medical foods, namely, food that is intended for the specific dietary management of a disease or condition; nutraceuticals for treating or restoring health in patients with diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints and whole body movement; dietary and nutritional supplements
Goods and Services
research and development of products in the nature of pharmaceutical preparations, medicines, medical foods, nutraceuticals, and dietary and nutritional foods and supplements; characterization of metrics and biomarkers, namely, development and evaluation of biochemical, biological or analytical assays to quantify biomarkers and surrogate markers, and epidemiological and natural history studies, for the identification of patients and the treatment or prevention of diseases, disorders and conditions associated with amino acid dysregulation, disruption of cellular homeostasis, protein energy dysfunction, the muscular system, the skeletal system, the cardiovascular system, the hematological system, the respiratory system, the hepatobiliary system, the gastrointestinal system, the endocrine system, the urinary system, the reproductive system, the immune system, the integumentary system, muscle, bones, joints, and whole body movement
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2016-06-14
Primary Code
042
First Use Anywhere Date
2016-06-11
First Use In Commerce Date
2016-06-11
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Correspondences
Name
Christina M. Licursi
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2016-06-09 | NEW APPLICATION ENTERED IN TRAM |
2016-06-14 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2016-09-16 | ASSIGNED TO EXAMINER |
2016-09-16 | NON-FINAL ACTION WRITTEN |
2016-09-16 | NON-FINAL ACTION E-MAILED |
2016-09-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2017-02-15 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
2017-03-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2017-03-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-03-17 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-04-05 | FINAL REFUSAL WRITTEN |
2017-04-05 | FINAL REFUSAL E-MAILED |
2017-04-05 | NOTIFICATION OF FINAL REFUSAL EMAILED |
2017-09-20 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
2017-09-20 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
2017-10-03 | TEAS AMENDMENT OF USE RECEIVED |
2017-10-04 | USE AMENDMENT FILED |
2017-10-04 | AMENDMENT TO USE PROCESSING COMPLETE |
2017-10-04 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
2017-10-04 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2017-10-04 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2017-10-11 | USE AMENDMENT ACCEPTED |
2017-10-11 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
2017-10-12 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |
2017-10-20 | ASSIGNED TO LIE |
2017-10-26 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
2017-11-28 | REGISTERED-SUPPLEMENTAL REGISTER |
2021-09-15 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |